Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 1990. Upgrade now.
Date Value
March 31, 2024 -5.57B
December 31, 2023 -4.81B
September 30, 2023 -4.119B
June 30, 2023 -2.552B
March 31, 2023 -8.087B
December 31, 2022 -9.119B
September 30, 2022 -2.358B
June 30, 2022 -1.93B
March 31, 2022 1.605B
December 31, 2021 2.593B
September 30, 2021 -1.242B
June 30, 2021 -2.819B
March 31, 2021 -3.44B
December 31, 2020 -2.832B
September 30, 2020 -6.215B
June 30, 2020 -5.516B
March 31, 2020 -8.737B
December 31, 2019 -8.861B
September 30, 2019 -12.42B
June 30, 2019 -11.17B
March 31, 2019 -12.05B
December 31, 2018 -13.16B
September 30, 2018 -13.38B
June 30, 2018 -10.94B
March 31, 2018 -14.19B
Date Value
December 31, 2017 -10.01B
September 30, 2017 -6.198B
June 30, 2017 -7.569B
March 31, 2017 -4.717B
December 31, 2016 -9.044B
September 30, 2016 -9.473B
June 30, 2016 -11.18B
March 31, 2016 -13.41B
December 31, 2015 -5.387B
September 30, 2015 -12.75B
June 30, 2015 -8.935B
March 31, 2015 -11.71B
December 31, 2014 -15.24B
September 30, 2014 -8.094B
June 30, 2014 -12.29B
March 31, 2014 -2.949B
December 31, 2013 -5.99B
September 30, 2013 -4.584B
June 30, 2013 -2.407B
March 31, 2013 -3.963B
December 31, 2012 -3.267B
September 30, 2012 -4.28B
June 30, 2012 -5.786B
March 31, 2012 -6.457B
December 31, 2011 -6.904B

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-12.42B
Minimum
Sep 2019
2.593B
Maximum
Dec 2021
-4.880B
Average
-4.464B
Median

Cash from Financing (TTM) Benchmarks

Amgen Inc -2.169B
Johnson & Johnson -21.42B
Eli Lilly and Co 2.772B
Pfizer Inc 23.91B
Moderna Inc -821.00M